prikaz prve stranice dokumenta Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms
  Download
PDF 152.95 KB
Scientific paper - Original scientific paper
Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms
Clinical Advances in Hematology and Oncology, 21 (2023), 10; 541-548. urn:nbn:hr:184:322235
Krečak, Ivan; Vestovšek, Srđan; Lucijanić, Marko

Cite this document

Krečak, I., Vestovšek, S. & Lucijanić, M. (2023). Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms. Clinical Advances in Hematology and Oncology, 21. (10), 541-548. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:322235

Krečak, Ivan, et al. "Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms." Clinical Advances in Hematology and Oncology, vol. 21, no. 10, 2023, pp. 541-548. https://urn.nsk.hr/urn:nbn:hr:184:322235

Krečak, Ivan, Srđan Vestovšek and Marko Lucijanić. "Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms." Clinical Advances in Hematology and Oncology 21, no. 10 (2023): 541-548. https://urn.nsk.hr/urn:nbn:hr:184:322235

Krečak, I., Vestovšek, S. and Lucijanić, M. (2023) 'Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms', Clinical Advances in Hematology and Oncology, 21(10), pp. 541-548. Available at: https://urn.nsk.hr/urn:nbn:hr:184:322235 (Accessed 03 December 2024)

Krečak I, Vestovšek S, Lucijanić M. Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms. Clinical Advances in Hematology and Oncology [Internet]. 2023 October [cited 2024 December 03];21(10):541-548. Available at: https://urn.nsk.hr/urn:nbn:hr:184:322235

I. Krečak, S. Vestovšek and M. Lucijanić, "Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms", Clinical Advances in Hematology and Oncology, vol. 21, no. 10, pp. 541-548, October 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:322235. [Accessed: 03 December 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms
AuthorIvan Krečak
AuthorSrđan Vestovšek
AuthorMarko Lucijanić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Oncology
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Cardiovascular (CV) risk factors are important contrib-utors to thrombotic risk in the general population and in patients with chronic myeloproliferative neoplasms (MPNs). However, the role of CV risk factors is often masked by other disease features that have a strong prognostic impact regarding thrombotic risk in MPN patients. This review summarizes the contemporary knowl-edge and aspects that have not been addressed or lack consensus in the medical community. We propose multidisciplinary care for MPN patients with CV comorbidities and provide future direc-tions that may be needed to appropriately manage CV risk factors in MPNs.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleClinical Advances in Hematology and Oncology
Numberingvol. 21, no. 10, pp. 541-548
e-ISSN1543-0790
URN:NBNurn:nbn:hr:184:322235
Publication2023-10
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) icon
Created on2023-11-13 10:02:15